ONDANSETRON HYDROCHLORIDE
ONDANSETRON HYDROCHLORIDE
Approval overview ONDANSETRON HYDROCHLORIDE is listed in Drugs@FDA under application 206846 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ONDANSETRON HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 2MG BASE/ML Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2023-05-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview ONDANSETRON HYDROCHLORIDE is listed in Drugs@FDA under application 206846 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ONDANSETRON HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 2MG BASE/ML Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2023-05-24 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.